Alison Dunning

researcher

Alison Dunning is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID0752407603.69
P496ORCID iD0000-0001-6651-7166
P6304researchportal.helsinki.fi profile IDalison-dunning
P10861Springer Nature person ID0752407603.69

P69educated atUniversity of LancasterQ262854
P108employerUniversity of CambridgeQ35794
University College LondonQ193196
P734family nameDunningQ21484695
DunningQ21484695
DunningQ21484695
P735given nameAlisonQ16154105
AlisonQ16154105
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q338488952q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Q57725936334 Predictive Value of Cardiac Computed Tomography and the Impact of Renal Function on All Cause Mortality in Confirm: Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
Q5792021935th Annual Meeting of the European Association for the Study of Diabetes
Q5688384435th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999
Q467113784-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q37005064A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding
Q101576446A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
Q55210146A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Q92224274A Mendelian randomization analysis of circulating lipid traits and breast cancer risk
Q57306192A candidate gene approach to searching for low-penetrance breast and prostate cancer genes
Q42676622A combined analysis of genome-wide association studies in breast cancer
Q46378338A common 8q24 variant in prostate and breast cancer from a large nested case-control study
Q57250674A common coding variant in CASP8 is associated with breast cancer risk
Q35755874A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer
Q45181384A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability
Q33980349A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians
Q24314996A gene (DLG2) located at 17q12-q21 encodes a new homologue of the Drosophila tumor suppressor dIg-A
Q39200585A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity
Q37332232A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk
Q34613513A genome-wide association scan on estrogen receptor-negative breast cancer
Q29417036A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
Q50104901A genome-wide association study to identify genetic markers associated with endometrial cancer grade.
Q34113217A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q35089479A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
Q36435849A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
Q92711687A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Q35699278A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Q71735471A polymorphic stop codon in BRCA2
Q35870483A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
Q61560753A postulated phylogenetic tree for the human apolipoprotein B gene: Unpredicted haplotypes are associated with elevated apo B levels
Q34286293A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy
Q37599352A role for XRCC2 gene polymorphisms in breast cancer risk and survival
Q33766628A systematic review of genetic polymorphisms and breast cancer risk.
Q42208433A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q44443237A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.
Q57726025ABSENCE OF CORONARY ARTERY CALCIUM DOES NOT FULLY EXCLUDE OBSTRUCTIVE CORONARY ARTERY DISEASE AND FUTURE ADVERSE EVENTS AMONG PATIENTS REFERRED FOR CARDIAC CT ANGIOGRAPHY: RESULTS FROM 17,528 PATIENTS IN THE CONFIRM REGISTRY (CORONARY CT ANGIOGRAPHY
Q56435657Abstract 20: POT1 mutations predispose to familial melanoma
Q64458508Abstract 5493: Genome-wide study of carboplatin and paclitaxel disposition in ovarian cancer patients
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q46931916Air pollution and risk of lung cancer in a prospective study in Europe
Q46586463Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer
Q57037855Amount of DNA in plasma and cancer risk: A prospective study
Q57278931An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found
Q61560794Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals
Q35242849Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q90666760Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium
Q35218520Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Q57305944Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q33279162Association between common variation in 120 candidate genes and breast cancer risk
Q43938987Association between epitopes detected by monoclonal antibody BIP-45 and the XbaI polymorphism of apolipoprotein B.
Q37292963Association of ESR1 gene tagging SNPs with breast cancer risk
Q46707380Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis
Q37684672Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Q46943040Association of gene variants in the TGF-beta signalling pathways with invasive breast cancer risk.
Q46935220Association of gene variants in the transforming growth factor beta signalling pathways with invasive breast cancer risk.
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q114182713Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Q36593602Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population
Q57306187Association of the Progesterone Receptor Gene with Breast Cancer Risk: A Single-Nucleotide Polymorphism Tagging Approach
Q35934138Association studies for finding cancer-susceptibility genetic variants
Q37151879Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer
Q57202712Associations among Mammographic Density, Circulating Sex Hormones, and Polymorphisms in Sex Hormone Metabolism Genes in Postmenopausal Women
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q63966080Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Q64118820Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Q61124964Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
Q60917552Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
Q60912720Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
Q38914005BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q57306056BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk
Q37298148Beyond GWASs: illuminating the dark road from association to function
Q46115524Body mass index and breast cancer survival: a Mendelian randomization analysis
Q100457582Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q35940158Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Q35562912Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study
Q46753298Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q33994241CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk
Q36419325CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer
Q33616702CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium
Q34180983CYP2D6 gene variants and their association with breast cancer susceptibility
Q21195205CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen
Q92005489Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Q92636519Candidate Causal Variants at the 8p12 Breast Cancer Risk Locus Regulate DUSP4
Q28385765Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
Q112645829Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses
Q92475989Chromatin interactome mapping at 139 independent breast cancer risk signals
Q94486442Combined associations of a polygenic risk score and classical risk factors with breast cancer risk
Q73139263Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population
Q24797594Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study
Q57265809Common Polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not Associated with Breast Cancer Risk
Q57306188Common Variants in RB1 Gene and Risk of Invasive Ovarian Cancer
Q36856357Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls
Q24658131Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer
Q34651737Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q45263043Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q73806219Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk
Q28237788Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival
Q46209474Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk
Q98390794Common susceptibility loci for male breast cancer
Q33947829Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers
Q115209587Common variants in breast cancer risk loci predispose to distinct tumor subtypes
Q57306185Common variants in mismatch repair genes and risk of colorectal cancer
Q35794359Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
Q21260438Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q42484694Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities
Q45960056Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations.
Q36026731Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q45772876Correction: Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study
Q43102129Corrigendum: Rare coding variants and X-linked loci associated with age at menarche
Q101216461Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
Q58136183DNA Polymorphism Studies. Approaches to Elucidating Multifactorial Ischaemic Heart Disease: the Apo B Gene as an Example
Q47734081DNA adducts and lung cancer risk: a prospective study
Q92762172DNA damage and hormone-related cancer: a repair pathway view
Q57037775DNA repair polymorphisms and cancer risk in non-smokers in a cohort study
Q44212883Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues
Q41925653Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer
Q58546894Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer
Q57707723Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes
Q27851413Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium
Q57252081Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers
Q48769845Educational attainment and mean leukocyte telomere length in women in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study.
Q64387842Effect of germ-line genetic variation on breast cancer survival in a population-based study
Q34778269Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study
Q33826873Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study
Q57250672Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk
Q40556983Errors in the polymerase chain reaction
Q34106703Establishment of a Radiogenomics Consortium
Q98184153European polygenic risk score for prediction of breast cancer shows similar performance in Asian women
Q40238343Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians
Q35653910Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Q36067788Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q102215596External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort
Q37594336FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Q37323340FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation
Q61560931Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases
Q35083710Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q33878276Fine scale mapping of the breast cancer 16q12 locus
Q36111237Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Q36856343Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression
Q55380382Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q55311842Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Q35063160Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Q39844032Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Q36248936Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q37002930Five endometrial cancer risk loci identified through genome-wide association analysis
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q46943059From association to cause: fine mapping of the TNRC9 gene region, a novel susceptibility locus identified in the first genome-wide association study for breast cancer.
Q38366358From candidate gene studies to GWAS and post-GWAS analyses in breast cancer
Q114182808Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Q33629880Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148
Q36124728Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Q34031757Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q40137431Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Q59138862Genetic Predictors of Normal Tissue Response to Radiotherapy
Q37389405Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer
Q115209620Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus
Q41687339Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor
Q108609948Genetic insights into biological mechanisms governing human ovarian ageing
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q54940815Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q52430637Genetic relationship between the 3'-VNTR and diallelic apolipoprotein B gene polymorphisms: haplotype analysis in individuals of European and south Asian origin
Q57252090Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers
Q28481918Genetic variants in ER cofactor genes and endometrial cancer risk
Q34497690Genetic variants in epigenetic genes and breast cancer risk.
Q35022825Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q46750307Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women
Q34038369Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q37131328Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies
Q24811147Genetic variation in the HSD17B1 gene and risk of prostate cancer
Q37311599Genetic variation in the chromosome 17q23 amplicon and breast cancer risk
Q36422109Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Q28388497Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q63681757Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Q93270780Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
Q37990107Genome-wide association studies and prediction of normal tissue toxicity
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q95329367Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Q29417135Genome-wide association study identifies a common variant associated with risk of endometrial cancer
Q29417050Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk
Q36024614Genome-wide association study identifies a possible susceptibility locus for endometrial cancer
Q34114293Genome-wide association study identifies five new breast cancer susceptibility loci
Q24645441Genome-wide association study identifies novel breast cancer susceptibility loci
Q52720511Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.
Q29416994Genome-wide association study identifies three new melanoma susceptibility loci
Q59795648Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
Q27008356Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Q47125417Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
Q28660394Genome-wide association study of endometrial cancer in E2C2
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q36019187Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
Q59566871Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility
Q38823212Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
Q47552886Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
Q96432094Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Q35798435Germline TERT promoter mutations are rare in familial melanoma
Q57266937Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation
Q114182677Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
Q34014453HSD17B1 genetic variants and hormone receptor-defined breast cancer
Q36612585HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q33330850Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Q119213179High-throughput allelic expression imbalance analyses identify candidate breast cancer risk genes
Q28303249Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer
Q57202722IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q39182862Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor
Q29417155Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Q36720814Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
Q36618927Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions
Q24653491Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women
Q36859142Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Q40648445Identification of genetic variation that determines levels of plasma triglycerides and hypercoagulability
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q58743933Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
Q34038964Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Q57170142Identification of nine new susceptibility loci for endometrial cancer
Q90091185Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants
Q36014067Identification of novel genetic markers of breast cancer survival
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q57202710Implications of Gene-Environment Interaction in Studies of Gene Variants in Breast Cancer: An Example of Dietary Isoflavones and the D356N Polymorphism in theSex Hormone-Binding GlobulinGene: Figure 1
Q38545794Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity
Q114184688Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Q34240634Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study
Q31116483Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients
Q34314677Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.
Q47586106Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q24652651Interactions between genes involved in the antioxidant defence system and breast cancer risk
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q41320578Is Southern blotting necessary to measure telomere length reproducibly? Authors' Response to: Commentary: The reliability of telomere length measurements
Q47190168Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q62583667Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology
Q40122475Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study
Q38730359Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
Q24288773Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q50793046Life stress, emotional health, and mean telomere length in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study.
Q33896984Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q34700093Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status
Q115161239Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium
Q114182490Mendelian randomisation study of smoking exposure in relation to breast cancer risk
Q98772941Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer
Q37283218Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer
Q36333368Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
Q63352621Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci
Q36180915Methodology of laboratory measurements in prospective studies on gene-environment interactions: the experience of GenAir
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q34736858Most common 'sporadic' cancers have a significant germline genetic component
Q53342282Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q33988405Multiple loci with different cancer specificities within the 8q24 gene desert
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q34057961No association between FTO or HHEX and endometrial cancer risk
Q35061078No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study
Q33982873No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk
Q36292769No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
Q53417363No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q37079859No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Q92476025Non-coding RNAs underlie genetic predisposition to breast cancer
Q37162103Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype
Q35752042Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q24563091POT1 loss-of-function variants predispose to familial melanoma
Q57315735PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION
Q34289136Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Q99408631Pathogenic Variants in CHEK2 Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast Cancer
Q112572520Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Q37307937Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium
Q36574725Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity
Q57306160Phytoestrogen Exposure Is Associated with Circulating Sex Hormone Levels in Postmenopausal Women and Interact with ESR1 and NR1I2 Gene Variants
Q57202732Phytoestrogen Exposure, Polymorphisms in COMT, CYP19, ESR1, and SHBG Genes, and Their Associations With Prostate Cancer Risk
Q45236801Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions.
Q57306194Polygenic Inherited Predisposition to Breast Cancer
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q44938215Polymorphisms associated with circulating sex hormone levels in postmenopausal women
Q43792195Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk
Q57306195Polymorphisms in DNA repair genes and epithelial ovarian cancer risk
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q36915870Polymorphisms in inflammation pathway genes and endometrial cancer risk
Q57202739Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men
Q53414081Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.
Q40386919Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma
Q95318005Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention
Q92055460Prediction and clinical utility of a contralateral breast cancer risk model
Q37487782Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q91832507Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts
Q62583372Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
Q35018327Progesterone receptor gene variants and risk of endometrial cancer
Q37318149Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression
Q35193839Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.
Q47177885Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
Q62839973Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q92503516Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
Q51762287Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Q51779676Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Q90242034Publisher Correction: Shared heritability and functional enrichment across six solid cancers
Q88214332Publisher correction: Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148
Q46003133Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids.
Q36009422RAD51B in Familial Breast Cancer
Q92122426RAPPER - A Success Story for Collaborative Translational Radiotherapy Research
Q57306176RAPPER: The Radiogenomics of Radiation Toxicity
Q92406757REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
Q57306197RESPONSE: Re: Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
Q64108927Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy
Q92633443Radiogenomics in the Era of Advanced Radiotherapy
Q30833608Radiogenomics: radiobiology enters the era of big data and team science
Q38294605Radiogenomics: the search for genetic predictors of radiotherapy response
Q57306190Radiosensitivity, Radiogenomics and RAPPER
Q29583867Rare and low-frequency coding variants alter human adult height
Q35961979Rare coding variants and X-linked loci associated with age at menarche
Q51102391Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition.
Q114182625Rare germline copy number variants (CNVs) and breast cancer risk
Q40094101Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks
Q35741115Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk
Q24794752Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q69024652Relationships between DNA and protein polymorphisms of apolipoprotein B
Q48943031Reproducibility of Telomere Length Assessment--An International Collaborative Study.
Q49111171Reproducibility of telomere length assessment: Authors' Response to Damjan Krstajic and Ljubomir Buturovic.
Q41935897Reproducibility of telomere length assessment: an international collaborative study
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q46776482Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers
Q91918447Runs of homozygosity and testicular cancer risk
Q36545934SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Q36672778STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics
Q36397260Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping
Q44086012Sampling distribution of summary linkage disequilibrium measures
Q33467087Seq4SNPs: new software for retrieval of multiple, accurately annotated DNA sequences, ready formatted for SNP assay design
Q57271433Sequence Variants of Estrogen Receptor and Risk of Prostate Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
Q61118451Shared heritability and functional enrichment across six solid cancers
Q64004349Shared heritability and functional enrichment across six solid cancers
Q21135356Shortened telomere length is associated with increased risk of cancer: a meta-analysis
Q36614423Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population
Q36835706Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer
Q33909674Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies
Q33593016Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Q35038651TGF-β signaling pathway and breast cancer susceptibility
Q33566957TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Q57037815TP53andKRAS2Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
Q33277172Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer
Q34486210Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer
Q91044035Targeted Resequencing of the Coding Sequence of 38 Genes Near Breast Cancer GWAS Loci in a Large Case-Control Study
Q35698038Telomere length and common disease: study design and analytical challenges
Q33794700Telomere length in prospective and retrospective cancer case-control studies
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q33300099The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study
Q91178389The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Q37578078The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers
Q57306198The Reliable Identification of Disease-Gene Associations
Q41206198The amino terminus of apolipoprotein B is necessary but not sufficient for microsomal triglyceride transfer protein responsiveness
Q34569981The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis
Q34333988The effect on melanoma risk of genes previously associated with telomere length
Q34144358The extent of linkage disequilibrium in four populations with distinct demographic histories
Q64998464The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium.
Q93054131The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis
Q29614700The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Q54796500The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk.
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q46364450The search for low-penetrance breast cancer genes.
Q114677146Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Q89961489Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
Q35195246Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human gene
Q92994868Two truncating variants in FANCC and breast cancer risk
Q115601277Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry
Q48346921Unequal crossing-over between two alu-repetitive DNA sequences in the low-density-lipoprotein-receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolaemia
Q50084544Use of deep whole genome sequencing data to identify structure risk variants in breast cancer susceptibility genes.
Q52725335Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer.
Q57725761Validation of the prognostic value of percentage total plaque score normalised to age on coronary computed tomography
Q34129771Variants in DNA double-strand break repair genes and breast cancer susceptibility
Q41672002XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

Search more.